These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15498674)

  • 1. Synthesis and biological evaluation of some 6-arylamidomorphines as analogues of morphine-6-glucuronide.
    Macdougall JM; Zhang XD; Polgar WE; Khroyan TV; Toll L; Cashman JR
    Bioorg Med Chem; 2004 Nov; 12(22):5983-90. PubMed ID: 15498674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, chemical synthesis, and biological evaluation of thiosaccharide analogues of morphine- and codeine-6-glucuronide.
    MacDougall JM; Zhang XD; Polgar WE; Khroyan TV; Toll L; Cashman JR
    J Med Chem; 2004 Nov; 47(23):5809-15. PubMed ID: 15509180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine.
    Francés B; Gout R; Campistron G; Panconi E; Cros J
    Prog Clin Biol Res; 1990; 328():477-80. PubMed ID: 2154808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, conformation, and biological characterization of a sugar derivative of morphine that is a potent, long-lasting, and nontolerant antinociceptive.
    Arsequell G; Salvatella M; Valencia G; Fernández-Mayoralas A; Fontanella M; Venturi C; Jiménez-Barbero J; Marrón E; Rodríguez RE
    J Med Chem; 2009 May; 52(9):2656-66. PubMed ID: 19351163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
    McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
    J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.
    Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC
    Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and biological evaluation of N-phenylalkyl-substituted tramadol derivatives as novel μ opioid receptor ligands.
    Shen Q; Qian YY; Xu XJ; Li W; Liu JG; Fu W
    Acta Pharmacol Sin; 2015 Jul; 36(7):887-94. PubMed ID: 26051109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.
    Adams JU; Tallarida RJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1261-7. PubMed ID: 8396630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
    Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
    Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
    Mathews JL; Peng X; Xiong W; Zhang A; Negus SS; Neumeyer JL; Bidlack JM
    J Pharmacol Exp Ther; 2005 Nov; 315(2):821-7. PubMed ID: 16076937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.
    Greiner E; Spetea M; Krassnig R; Schüllner F; Aceto M; Harris LS; Traynor JR; Woods JH; Coop A; Schmidhammer H
    J Med Chem; 2003 Apr; 46(9):1758-63. PubMed ID: 12699394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
    Tham SM; Angus JA; Tudor EM; Wright CE
    Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-related metabolites differentially activate adenylyl cyclase isozymes after acute and chronic administration.
    Eckhardt K; Nevo I; Levy R; Mikus G; Eichelbaum M; Vogel Z
    FEBS Lett; 2000 Mar; 470(3):309-14. PubMed ID: 10745087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro biological evaluation of a carbon glycoside analogue of morphine-6-glucuronide.
    MacDougall JM; Zhang XD; Polgar WE; Khroyan TV; Toll L; Cashman JR
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1583-6. PubMed ID: 15745801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphine-6-glucuronide, an active morphine metabolite for the potential treatment of post-operative pain.
    Joshi GP
    Curr Opin Investig Drugs; 2008 Jul; 9(7):786-99. PubMed ID: 18600584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3H-morphine-6beta-glucuronide binding in brain membranes and an MOR-1-transfected cell line.
    Brown GP; Yang K; Ouerfelli O; Standifer KM; Byrd D; Pasternak GW
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1291-7. PubMed ID: 9316837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine.
    Frances B; Gout R; Monsarrat B; Cros J; Zajac JM
    J Pharmacol Exp Ther; 1992 Jul; 262(1):25-31. PubMed ID: 1320685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.